Plant Medicines: New Therapeutic Uses
A special issue of Medicines (ISSN 2305-6320).
Deadline for manuscript submissions: closed (30 November 2024) | Viewed by 460
Special Issue Editor
Interests: chronic pain; severe pain; plant medicines; traditional healing; California Indian healing
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Clinical trials focused on plant-derived medicines are being conducted in China, India, Europe and other places. These trials seek to prove the efficacy, safety and environmental sustainability of plant medicines. The advantage of plant medicines is that the human body has been exposed to them for thousands of years and may have adapted to them. Many of these medicines are useful when therapies are limited by resistance and toxicity problems. However, plant medicines should be tested in clinical trials to prove their purity, efficacy and safety. The chemistry and mechanisms of action underlying these medicines should be reported. They should also be examined for environmental sustainability. Plant species that are uncommon should be grown in farms to make their use sustainable.
Prof. Dr. James David Adams
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- depression
- psychosis
- stroke
- heart disease
- pain
- bacterial and viral infection
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
